Olan, Ioana https://orcid.org/0000-0003-0692-1831
Parry, Aled J. https://orcid.org/0000-0001-5192-3727
Schoenfelder, Stefan https://orcid.org/0000-0002-3200-8133
Narita, Masako https://orcid.org/0000-0002-9774-4908
Ito, Yoko https://orcid.org/0000-0003-4578-6126
Chan, Adelyne S. L.
Slater, Guy St.C.
Bihary, Dóra https://orcid.org/0000-0001-7871-7288
Bando, Masashige
Shirahige, Katsuhiko
Kimura, Hiroshi https://orcid.org/0000-0003-0854-083X
Samarajiwa, Shamith A. https://orcid.org/0000-0003-1046-0601
Fraser, Peter https://orcid.org/0000-0002-0041-1227
Narita, Masashi https://orcid.org/0000-0001-7764-577X
Funding for this research was provided by:
Wellcome Trust (105367/Z/14/Z, 215912/Z/19/Z)
RCUK | Biotechnology and Biological Sciences Research Council (BB/J004480/1, BB/J004480/1, BB/S013466/1)
RCUK | Medical Research Council (MR/T016787/1, MC_UU_12022/10, MR/L007150/1, MR/M013049/1)
Babraham Institute (Career Progression Fellowship)
Cancer Research UK (C9545/A29580, C9545/A29580, C9545/A29580, C9545/A29580)
MEXT | Japan Society for the Promotion of Science (15H05976, 15H05976, JP17H01417, JP18H05527)
MEXT | JST | Core Research for Evolutional Science and Technology (JPMJCR16G1)
Article History
Received: 25 October 2019
Accepted: 30 October 2020
First Online: 27 November 2020
Competing interests
: P.F. and S.S. are co-founders Enhanc3D Genomics Ltd. All other authors declare no competing interests.